|
Acetazolamide
Carbonic Anhydrase Inhibitor
|
Proximal Convoluted Tubule (PCT) |
↓ HCO3-, ↓ K+, ↑ urinary pH, normal/mild ↓ Na+ |
Glaucoma (decreases aqueous humor production), Altitude Sickness / AMS (produces mild metabolic acidosis to stimulate respiratory drive), Idiopathic Intracranial Hypertension (pseudotumor cerebri). |
Hyperchloremic metabolic acidosis (Type 2 RTA), hypokalemia, calcium phosphate kidney stones (insoluble in alkaline urine), sulfa allergy. |
|
Furosemide / Bumetanide
Loop Diuretics (Sulfonamides)
|
Thick Ascending Limb (TAL) |
↓↓ Na+, ↓↓ K+, ↓↓ Cl-, ↓ Ca2+ (hypercalciuria), ↓ Mg2+, ↑ HCO3- (metabolic alkalosis) |
Acute Pulmonary Edema, Congestive Heart Failure, Cirrhotic ascites, Hypercalcemia (promotes calciuria), Renal failure fluid overload. |
Mnemonic OH DANG!: Ototoxicity (tinnitus, hearing loss), Hypokalemia & Hypomagnesemia, Dehydration / hypotension, Allergy (sulfa), Nephritis (acute interstitial), Gout (hyperuricemia via URAT1 competition). |
|
Ethacrynic Acid
Loop Diuretic (Phenoxyacetic derivative)
|
Thick Ascending Limb (TAL) |
↓↓ Na+, ↓↓ K+, ↓ Ca2+, ↓ Mg2+, ↑ HCO3- |
Patients requiring aggressive loop diuresis who have a severe, documented sulfa allergy (e.g. anaphylaxis to sulfonamides). |
More ototoxic than furosemide; hyperuricemia, hypokalemic metabolic alkalosis. |
|
Hydrochlorothiazide / Chlorthalidone
Thiazide Diuretics
|
Early Distal Convoluted Tubule (DCT) |
↓ Na+, ↓ K+, ↑ Ca2+ (HYPERCALCEMIA / hypocalciuria), ↓ Mg2+, ↑ HCO3- (metabolic alkalosis) |
Essential Hypertension (first-line), Recurrent Calcium Nephrolithiasis (reduces urinary Ca2+ excretion), Nephrogenic Diabetes Insipidus (paradoxical reduction in urine output). |
Mnemonic HyperGLUC: HyperGlycemia (decreases insulin release), HyperLipidemia (elevates LDL and triglycerides), HyperUricemia (precipitates gout), HyperCalcemia. Hypokalemic metabolic alkalosis, hyponatremia. |
|
Spironolactone / Eplerenone
Aldosterone Receptor Antagonists
|
Cortical Collecting Tubule (Principal Cells) |
↓ Na+, ↑ K+ (HYPERKALEMIA), ↓ HCO3- (mild metabolic acidosis) |
Heart Failure with reduced Ejection Fraction (HFrEF - proven mortality benefit!), Primary Hyperaldosteronism (Conn syndrome), Hepatic Cirrhosis ascites, Resistant Hypertension. |
Hyperkalemia (fatal arrhythmias), endocrine side effects due to cross-reactivity with androgen and progesterone receptors: Gynecomastia, decreased libido, erectile dysfunction, menstrual irregularities (Spironolactone >> Eplerenone; Eplerenone is more selective!). |
|
Amiloride / Triamterene
Direct ENaC Blockers (K+-Sparing)
|
Cortical Collecting Tubule (Principal Cells) |
↓ Na+, ↑ K+ (HYPERKALEMIA), ↓ H+ secretion |
Liddle Syndrome (constitutive ENaC activation), Lithium-induced Nephrogenic Diabetes Insipidus (Amiloride blocks lithium entry into principal cells via ENaC!), combined with loop/thiazide diuretics to prevent hypokalemia. |
Hyperkalemia, metabolic acidosis. Triamterene can precipitate in tubules causing triamterene kidney stones. |